Evaluation of Incidental Thyroid Nodules in Cancer Patients

Slides:

Advertisements

Similar presentations

The Thyroid Incidentaloma

Advertisements

Incidentally find an adrenal tumor on health screening by FDG-PET/CT Nan-Jing Peng, MD Department Nuclear Medicine.

Unexpected additional thyroid cancer in a patient with already known cervical cancer detected on PET/CT Kaohsiung Veterans General Hospital Kuan-Hsiu Lin,

Date of download: 6/1/2016 From: Cost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules Ann Intern Med. 2003;138(9):

Fig. 9. Warthin's tumor, a 72-year-old man with supraglottic cancer. A

Fig. 2. Arterial fluorodeoxyglucose (FDG) uptake related to atherosclerosis. On positron emission tomography (PET) coronal (A), PET/CT fusion coronal (B),

Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer Nadya Shusharina, PhD,

Ultrasound stratification of the FDG-avid thyroid nodule

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer Eur Thyroid J 2016;5:

Evaluation of 18F-FDG PET-CT for Differentiation of Pulmonary Pathology in an Approach of Outpatient Fast Track Assessment Tjeerd S. Aukema, MD, Renato.

Stage IV non–small cell lung cancer (NSCLC)

Incidental significant finding on FDG-PET/CT

Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.

FDG PET-CT Aids in the Preoperative Assessment of Patients with Newly Diagnosed Thymic Epithelial Malignancies Marcelo F.K. Benveniste, MD, Cesar A.

Gingival Metastasis as First Sign of Multiorgan Dissemination of Epithelioid Malignant Mesothelioma Andrea Billè, Marco Platania, Giuseppe Pelosi, Barbara.

Scott J. Adams, MD, Rajan Rakheja, MD, Rhonda Bryce, MD, Paul S

The Comparison of Computed Tomography Perfusion, Contrast-Enhanced Computed Tomography and Positron-Emission Tomography/Computed Tomography for the Detection.

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer Ernest Nadal,

TB Determined: Tuberculous Osteomyelitis

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.

Paraneoplastic Limbic Encephalitis and Small-Cell Lung Carcinoma

Resection of Mucinous Lung Adenocarcinoma Presenting with Intractable Bronchorrhea Motoshi Takao, MD, PhD, Takehiro Takagi, MD, Hitoshi Suzuki, MD, PhD,

The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients.

Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography Gustaf Tegler, MD, Jens Sörensen,

A difficult case: Ectopic thyroid, bronchial anomalies, and incidentaloma in a patient with lung carcinoma Salih Topcu, MD, Serife Tuba Liman, MD, Aykut.

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

Diffusion-Weighted Magnetic Resonance Imaging for Diagnosing Malignant Pulmonary Nodules/Masses: Comparison with Positron Emission Tomography Takeshi.

Positron emission tomographic imaging with fluorodeoxyglucose is efficacious in evaluating malignant pulmonary disease Geoffrey M. Graeber, MD*, Naresh.

When is it Best to Repeat a 2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography/Computed Tomography Scan on Patients with Non-Small Cell Lung Cancer.

Cost-Effectiveness of Initial Diagnostic Strategies for Pulmonary Nodules Presenting to Thoracic Surgeons Stephen A. Deppen, MA, MS, William T. Davis,

Hibernoma: 18F FDG PET/CT Imaging

Role of Integrated 18-Fluorodeoxyglucose Position Emission Tomography-Computed Tomography in Patients Surveillance after Multimodality Therapy of Malignant.

Follow-Up of Patients after Stereotactic Radiation for Lung Cancer: A Primer for the Nonradiation Oncologist Kitty Huang, MSc, MDCM, David A. Palma,

Preliminary Report of Late Recurrences, at 5 Years or More, after Stereotactic Body Radiation Therapy for Non-small Cell Lung Cancer Yukinori Matsuo,

Incidental finding of malignancy in patients preoperatively evaluated for aneurysm wall pathology using PET/CT Maarten Truijers, MD, Jillis A. Pol, MD,

The role of positron emission tomography for non-small cell lung cancer Albert J. Chang, MD, PhD, Farrokh Dehdashti, MD, Jeffrey D. Bradley, MD Practical.

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Interpretation Criteria for Assessment of Antibiotic Treatment Response in Pyogenic.

Yasuo Miura, MD, PhD, Mitsuru Tsudo, MD, PhD Mayo Clinic Proceedings

A Pilot Study of Preoperative Gefitinib for Early-Stage Lung Cancer to Assess Intratumor Drug Concentration and Pathways Mediating Primary Resistance

Stereotactic Ablative Radiation Therapy for Lung Oligometastases: Predictive Parameters of Early Response by 18FDG-PET/CT Rosario Mazzola, MD, Alba Fiorentino,

Frequency of Lymph Node Metastasis According to the Size of Tumors in Resected Pulmonary Adenocarcinoma with a Size of 30 mm or Smaller Yangki Seok,

Clinicopathological Characteristics of Screen-Detected Lung Cancers

A Patient With BRAF V600E Lung Adenocarcinoma Responding to Vemurafenib Oliver Gautschi, MD, Chantal Pauli, MD, Klaus Strobel, MD, Astrid Hirschmann,

PET/CT Findings for Bone Marrow Carcinosis Because of Lung Adenocarcinoma Keisuke Watanabe, MD, Masaharu Shinkai, MD, PhD, Kenjiro Nagai, MD, Nobuhiro.

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.

Value of Combined Interpretation of Computed Tomography Response and Positron Emission Tomography Response for Prediction of Prognosis After Neoadjuvant.

Analysis of Tumor Markers in the Cytological Fluid Obtained from Computed Tomography-Guided Needle Aspiration Biopsy for the Diagnosis of Non-small Cell.

Acute intramural hematoma of the aorta as a cause of positive fluorodeoxyglucose positron emission tomography/computed tomography Alex Ryan, MD, Barry.

A Case of Nontuberculous Mycobacteria Highly Suspected as Lung Cancer Invading the Aortic Arch Tadashi Umehara, MD, Masaya Aoki, MD, PhD, Aya Harada,

Osimertinib for Epidermal Growth Factor Receptor Mutation–Positive Lung Adenocarcinoma That Transformed to T790M-Positive Squamous Cell Carcinoma Naoyuki.

Axillary Mass and Hypercalcemia: The Value of a Physical Examination

Detection of an Asymptomatic Right-Ventricle Cardiac Metastasis from a Small-Cell Lung Cancer by F-18-FDG PET/CT Maria Victoria Orcurto, MD, Angelika.

Osteoblastic Bone Flare on F18-FDG PET in Non-small Cell Lung Cancer (NSCLC) Patients Receiving Bevacizumab in Addition to Standard Chemotherapy Yelena.

Matthew Reichert, MD, Eric S. Bensadoun, MD

Histological Subtypes of Lung Adenocarcinoma Have Differential 18F- Fluorodeoxyglucose Uptakes on the Positron Emission Tomography/Computed Tomography.

Evaluating the Patient With Diarrhea: A Case-Based Approach

Nicholas W. Choong, MD, Robert S. Hellman, MD

Beware of the “Bronchocele,” Particularly in Patients with a History or Risk Factors for a Mucinous Carcinoma: A Response to the Article “Resection of.

Antiangiogenesis Induced Tumor Cavitation in Lung Cancer

False-Positive FDG-PET and Bronchial Anthracofibrosis

Successful AZD9291 Therapy Based on Circulating T790M

Textiloma on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: A Wolf in a Sheep's Clothing? David Petermann, MD, Michel Christodoulou,

EBUS-TBNA for the Clarification of PET Positive Intra-Thoracic Lymph Nodes—an International Multi-Centre Experience Robert C. Rintoul, FRCP, PhD, Kurt.

Prognostic Role of Positron Emission Tomography and High-Resolution Computed Tomography in Clinical Stage IA Lung Adenocarcinoma Hirofumi Uehara, MD,

Fig. 2. SUVmax on PET-CT and associated characteristics

Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy Matthew S. Block, MD, PhD, Robert Vassallo,

Super Scan Using Positron Emission Tomography in Lung Cancer Patients

Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D

Sebastien Gilbert, MD, David O. Wilson, MD, MPH, Neil A

Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT Shuichi.

Presentation transcript:

Evaluation of Incidental Thyroid Nodules in Cancer Patients Güven Barış Cansu, M.D., Nusret Yılmaz, M.D., Serap Toru, M.D., Ramazan Sarı, M.D., Güzide Gökhan Ocak, M.D., Cumhur Arıcı, M.D., Hasan Ali Altunbaş, M.D., Mustafa Kemal Balcı, M.D. Journal of the National Medical Association DOI: 10.1016/j.jnma.2017.02.011 Copyright © 2017 National Medical Association Terms and Conditions

Figure 1 Design of the study. FNAB: fine needle aspiration biopsy, PET: positron emission tomography, CT: computed tomography, Ca: cancer. Journal of the National Medical Association DOI: (10.1016/j.jnma.2017.02.011) Copyright © 2017 National Medical Association Terms and Conditions

Figure 2 Receiver operating characteristics (ROC) curve of FDG PET/CT according to maximal standardized uptake value (SUVmax) to differentiate benign and malignant thyroid incidentalomas. The area under the curve (AUC) of FDG PET/CT is 0.932. Journal of the National Medical Association DOI: (10.1016/j.jnma.2017.02.011) Copyright © 2017 National Medical Association Terms and Conditions